Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baron Capital is a private U.S. asset management and investment firm founded in 1982 by Ron Baron. The firm focuses on long-term, fundamental, research-driven growth equity investing and offers mutual funds, institutional strategies, and active ETFs. While it operates a health care-focused investment strategy and mutual fund, Baron Capital is not itself a biotech, pharma, healthcare operating company and does not develop therapeutics or medical products. Its business is financial services, centered on portfolio management and investment research across multiple sectors, including health care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baron Capital Group.